- Home
- UVE vs KOD Comparison
UVE vs KOD Comparison
Compare UVE & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UVE
- KOD
- Stock Information
- Founded
- UVE 1990
- KOD 2009
- Country
- UVE United States
- KOD United States
- Employees
- UVE N/A
- KOD N/A
- Industry
- UVE Property-Casualty Insurers
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UVE Finance
- KOD Health Care
- Exchange
- UVE Nasdaq
- KOD Nasdaq
- Market Cap
- UVE 546.2M
- KOD 454.7M
- IPO Year
- UVE 1992
- KOD 2018
- Fundamental
- Price
- UVE $21.09
- KOD $3.65
- Analyst Decision
- UVE Buy
- KOD Hold
- Analyst Count
- UVE 1
- KOD 4
- Target Price
- UVE $25.00
- KOD $8.00
- AVG Volume (30 Days)
- UVE 170.4K
- KOD 308.6K
- Earning Date
- UVE 04-24-2025
- KOD 03-27-2025
- Dividend Yield
- UVE 3.64%
- KOD N/A
- EPS Growth
- UVE N/A
- KOD N/A
- EPS
- UVE 2.01
- KOD N/A
- Revenue
- UVE $1,520,536,000.00
- KOD N/A
- Revenue This Year
- UVE N/A
- KOD N/A
- Revenue Next Year
- UVE $3.77
- KOD N/A
- P/E Ratio
- UVE $10.53
- KOD N/A
- Revenue Growth
- UVE 9.27
- KOD N/A
- 52 Week Low
- UVE $16.50
- KOD $2.19
- 52 Week High
- UVE $23.39
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- UVE 53.09
- KOD 28.91
- Support Level
- UVE $20.60
- KOD $3.42
- Resistance Level
- UVE $22.61
- KOD $3.85
- Average True Range (ATR)
- UVE 0.78
- KOD 0.36
- MACD
- UVE -0.03
- KOD 0.05
- Stochastic Oscillator
- UVE 51.75
- KOD 13.14
About UVE UNIVERSAL INSURANCE HOLDINGS INC
Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums. It operates within Florida and across the United States. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.